DoxyPEP could play a pivotal role in stopping the recent surge in STIs, but what is it and who could it be useful for? WORDS BY CONOR CLARK HEADER IMAGE BY ANISA CLEAVER SPECIAL THANKS TO THE LOVE TANK As sexually transmitted infections (STIs) continue to be diagnosed at record levels, sexual health experts are continuously looking for new ways to stop the spread.
Doxycycline post-exposure prophylaxis, known more commonly as DoxyPEP, is among the latest innovations being considered as a way of protecting those who are most at risk.
Despite not yet being rolled out in the UK, DoxyPEP has seen success at sexual health clinics in cities like San Francisco, fuelling discussion over whether or not this should be replicated elsewhere – but what is it, are there side effects and what STIs does it help prevent?
GAY TIMES worked with Dr. Benjamin Weil, Programme Coordinator: Community Knowledge Generation and Research at The Love Tank, a not-for-profit community interest community that promotes the health and wellbeing of underserved groups, to tell you what you need to know about DoxyPEP.